Virologists are beginning to assess which other viruses could have pandemic potential
The FTSE 100 index closed 0.3% lower, weighed by weakness in miners and insurance… The post UK shares drop after Sunak’s forecast first appeared on Trading...
China's struggling small and medium-sized manufacturers will see their taxes deferred for three months from November to help them cope with the high price of raw...
Covid-19 is slowly retreating across most of North, Central and South America, the Pan American Health Organization (PAHO) said on Oct. 27, reporting that last week...
Spain’s on-demand delivery platform Glovo has announced what it’s calling “The Couriers Pledge” — an initiative which commits its business to setting a new — “fairer”...
Another weapon against Covid-19 could be made more prominent as results from a large, placebo-controlled trial published in the Lancet on Wednesday evening provide compelling evidence...
Can these penny stocks show potential at current prices? The post Are These Penny Stocks Bargains at Current Levels? appeared first on Penny Stocks to Buy,...
How Long Until Supply Chains Finally Normalize: Three Things To Watch Earlier today, Morgan Stanley showed that more than inflation, more than concerns about the historic...
Sunak talked about a new age of optimism, but it doesn’t feel like that for many people.
Teva Pharmaceutical Industries Ltd. inked a deal to license and develop two of MODAG GmbH’s compounds in neurodegenerative disease.
Malvern, Pa.-based Ocugen submitted an Investigational New Drug Application to the U.S. Food and Drug Administration to run a Phase III trial of India’s Covid-19 vaccine BBV152...
Gringo, a Brazilian startup that has built an app aimed at supporting drivers in a variety of ways, has raised $8 million in a new round...
Are these consumer staples a must-have in your portfolio now? The post Best Stocks To Buy Today? 4 Consumer Staples Stocks For Your List appeared first...
Loonie Soars After Bank of Canada Ends QE Early, Accelerates Rate Hike Timing To Mid-2022 Another day, another hawkish surprise from a developed central bank. While...
GM Shares Slump Despite Company Raising Full Year Guidance Semiconductor shortage or not, General Motors posted a Q3 report that handily beat the street's estimates. The...
30Y Gilts Soar Most Since Covid Crisis In Giant Short Squeeze After UK Slashes Debt Issuance While it is of secondary importance to US readers, in...
A UBC-led research team has uncovered how the virus responsible for causing COVID-19 escapes destruction in infected cells, allowing SARS-CoV-2 to persist and continue spreading in...
GlaxoSmithKline said today it would halt further development of its antibody for severe COVID-19 pneumonia – otilimab – The post GSK side-lines COVID drug otilimab to...
Merck & Co has signed a licensing deal with the UN-backed Medicines Patent Pool (MPP) that could pave The post Merck takes further steps to expand...
The euro is treading in calm waters on Wednesday, ahead of the ECB policy meeting tomorrow. Currently, EUR/USD is trading at 1.1595, down 0.01% on the...
By Kristalina Georgieva G20 should lead in sharing vaccine doses, helping developing countries financially, and committing to reaching net-zero carbon emissions by mid-century. When G20 leaders...
Naturally Splendid Enterprises Ltd. (“Naturally Splendid“, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce that a selection of NATERA Plant-Based Foods were featured...
From the indie to the blockbuster, Halloween viewing recommendations whatever your taste.
Listen to the fourth episode of a new series from The Anthill Podcast ahead of the COP26 climate change summit in Glasgow.
This is a transcript of part 4 of Climate Fight: the world’s biggest negotiation, a series from The Anthill podcast.
South African online healthcare marketplace RecoMed has raised a $1.5 million financing round, the company confirmed to TechCrunch. The round was led by South Africa-focused venture...
Its proprietary fermentation process will enable QOA to scale production by 2035 and be able to price its "chocolate" products the same or below the cost...
Cases are high in people over 60, who are far more likely to develop severe COVID and need hospital treatment.
The small executive team at Cardurion has been sticking carefully to its goals, in-licensing a lead cardio drug from Astellas in 2018 and making a careful...
Re-Imposing COVID Restrictions Would Cost UK Up To £18 Billion Authored by Paul Joseph Watson via Summit News, Boris Johnson has been warned that any move...